Testing Antisense Oligonucleotide Effectiveness Using Spheroid Models

This opportunity involves generating 3D spheroid models and conducting efficacy testing of antisense oligonucleotides to evaluate their ability to reduce cell growth. The work, awarded to Alcyomics Limited, focuses on developing and validating experimental systems that can measure how effectively antisense oligonucleotides inhibit growth in spheroid cultures. Suppliers and researchers should understand that this project requires expertise in spheroid generation techniques, antisense oligonucleotide formulation, and cell growth assessment methodologies. The objective is to establish reliable testing protocols that can demonstrate the therapeutic potential of antisense oligonucleotides as growth-inhibiting agents.